References
- COVID-19 Timeline: cDC. 2022 [updated Aug 16 2022; cited 2022 dec 01 2022]. cited 2022 dec 01 2022: https://www.cdc.gov/museum/timeline/covid19.html
- Hopkins J New COVID-19 cases worldwide: johns hopkins university & medicine; 2023 [cited 12 jan 2022]. Available from: New COVID-19 Cases Worldwide - Johns Hopkins Coronavirus Resource Center (jhu.edu)
- Goel R, Chappidi MR, Patel EU, et al. Trends in red blood cell, plasma, and platelet transfusions in the United States, 1993-2014. JAMA. 2018 Feb 27;319(8):825–827. DOI:10.1001/jama.2017.20121
- Goel R, Zhu X, Patel EU, et al. Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018. Blood Adv. 2021 Oct 26;5(20):4179–4184. DOI:10.1182/bloodadvances.2021005361
- Gilcher RO. Two oklahoma city disasters: the oklahoma city bombing and the tornadoes–a blood bank perspective. Proc (Bayl Univ Med Cent). 2001 Apr;14(2):140–143.
- Cross AR How disasters affect the blood supply for patients in need: the american national red cross; 2018 [dec 15 2022]. Available from: https://redcrosschat.org/2018/10/17/how-disasters-affect-the-blood-supply-for-patients-in-need
- Cross AR How to Help in the Wake of Hurricane Ian. . www.redcrossblood.org/local-homepage/news/article/hurricanes-blood-donation.html
- Irisawa AT. Great East Japan earthquake: a report of a regional hospital in Fukushima Prefecture coping with the Fukushima nuclear disaster. Dig Endosc. 2012 May;24(1):3–7.
- Shinar E, Yahalom V, Silverman BG. Meeting blood requirements following terrorist attacks: the Israeli experience. Curr Opin Hematol. 2006 Nov;13(6):452–456.
- Haddad A, Bou Assi T, Garraud O. Can a decentralized blood system ensure self-sufficiency and blood safety? The Lebanese experience. J Public Health Policy. 2017 Aug;38(3):359–365.
- Gammon RR, Rosenbaum L, Cooke R, et al. Maintaining adequate donations and a sustainable blood supply: lessons learned. Transfusion. 2021 Jan;61(1):294–302.
- Schmidt PJ. Blood and disaster–supply and demand. N Engl J Med. 2002 Feb 21;346(8):617–620. DOI:10.1056/NEJM200202213460813
- Shan H, Zhang P. Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing. Transfusion. 2004 Apr;44(4):467–469.
- Kuruppu KK. Management of blood system in disasters. Biologicals. 2010;38(1):87–90.
- Lozada MJ, Cai S, Li M, et al. The las vegas mass shooting: an analysis of blood component administration and blood bank donations. J Trauma Acute Care Surg. 2019 Jan;86(1):128–133.
- Stanworth SJ, New HV, Apelseth TO, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020 Oct;7(10):e756–764. DOI:10.1016/S2352-3026(20)30186-1
- FEMA. Emergency management in the United States 2023. [cited 2023 Feb 5];Unit 4: Available fromhttps://training.gema.gov/emiweb/downloads/is111_unit%204.pdf
- Zimrin AB, Hess JR. Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States. Transfusion. 2007 Jun;47(6):1071–1079.
- Oloruntoba R, Sridharan R, Davison G. A proposed framework of key activities and processes in the preparedness and recovery phases of disaster management. Disasters. 2018 Jul;42(3):541–570.
- Gschwender A, Gillard L. Disaster preparedness in the blood bank. Clinical Laboratory Science. 2017;30(4):250–257.
- Cross AR Red Cross urges Blood Donation in Areas Unaffected by Ian. 2022. www.redcross.org/about-us/news-and-events/news/2022/red-cross-sends-blood-to-florida-in-advance-of-hurricane-ian.html
- In Türkiye and Syria, Red Crescent Teams Responding to Earthquake [Internet]. Feb 7, 2023 [cited Feb 7, 2023]. Available from: www.redcross.org/about-us/news-and-events/news/2023/red-crescent-teams-responding-to-earthquake-in-turkey-and-syria.html
- Wetheimer T Turkey earthquake: death toll could increase eight-fold, WHO says 2023 [updated Feb 7 2023; February 8, 2023]. Available from: www.bbc.com/news/world-europe-64533851
- Fortis SP, Kriebardis AG, Georgatzakou HT, et al. Economic crisis in Greece: the invisible enemy of blood donation or not? Transfus Apher Sci. 2022 Dec;61(6):103467.
- Abdella Y, Hajjeh R, Sibinga CTS. Availability and safety of blood transfusion during humanitarian emergencies. East Mediterr Health J. 2018 Oct 10;24(8):778–788.
- Tayfur I, Günaydin M, Suner S. Healthcare service access and utilization among syrian refugees in turkey. Ann Glob Health. 2019 Mar 20;85(1). DOI:10.5334/aogh.2353.
- Attacks on health care: world heath organization regional office for the easter mediterranean; 2016 [nov 15 2022]. Available from: http://www.emro.who.int/eha/attacks-on-health-care/index.html
- Soffer D, Klausner J, Bar-Zohar D, et al. Usage of blood products in multiple-casualty incidents: the experience of a level I trauma center in Israel. Arch Surg. 2008 Oct;143(10):983–989. discussion 989. DOI:10.1001/archsurg.143.10.983
- Bala M, Kaufman T, Keidar A, et al. Defining the need for blood and blood products transfusion following suicide bombing attacks on a civilian population: a level I single-centre experience. Injury. 2014 Jan;45(1):50–55.
- Hosseini Divkolaye NS, Seighali F, Pourfathollah AA, et al. Meeting the challenges of international crises: the experience of the iranian blood transfusion organization. Disaster Med Public Health Prep. 2019 Jun;13(3):410–413.
- El Sayed MJ. Emergency response to mass casualty incidents in Lebanon. Disaster Med Public Health Prep. 2013 Aug;7(4):433–438.
- Haddad A, Bou Assi T, Haddad L, et al. Difficulties in achieving a sustainable blood supply: report from the first national seminar on blood donation in Lebanon. East Mediterr Health J. 2020 Jun 24;26(6):736–743. DOI:10.26719/emhj.19.070
- Glynn SA, Busch MP, Schreiber GB, et al. Effect of a national disaster on blood supply and safety: the September 11 experience. JAMA. 2003 May 7;289(17):2246–2253. DOI:10.1001/jama.289.17.2246
- Starr D. Bad Blood: the 9/11 blood-donation disaster: the new republic Online; 2002 [Feb 3, 2023]. Available from: https://www.theopennotebook.com/wp-content/uploads/2012/06/TNR-BAD-BLOOD.pdf
- AR C. Joint statement: blood donors urgently needed during national blood donor month and throughout the winter: the american national red cross; Jan 10, 2022 [nov 16 2022]. Available from: www.redcross.org/about-us/news-and-events/press-release/2022/joint-statement-blood-donors-urgently-needed.html
- AABBDisaster Operations HandBook. 2.0 ed. Bethesda, Maryland, USA: AABB; 2008. p. 128.
- Devi S. Economic crisis hits lebanese health care. Lancet. 2020 Feb 22;395(10224):548.
- Lebanon: Hospital Crisis Endangering Health. Human Rights WatchDecember 10, 2019.
- Alfieri S, Guiddi P, Marta E, et al. Economic crisis and blood donation: how are donors’ motivations changing? Transfus Apher Sci. 2016 Jun;54(3):396–400.
- Tsubokura M, Nakada H, Matsumura T, et al. The impact of H1N1 influenza a virus pandemic on the blood donations in Hyogo Prefecture, Japan. Transfusion. 2010 Aug;50(8):1803–1805.
- Ong CW, Ho KY, Hsu LY, et al. Reacting to the emergence of swine-origin influenza a H1N1. Lancet Infect Dis. 2009 Jul;9(7):397–398.
- Teo D. Blood supply management during an influenza pandemic. ISBT Sci Series. 2009;4(2):293–298.
- Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003 Sep 25;349(13):1236–1245. DOI:10.1056/NEJMoa030969
- Busch MP, Young MJ, Samson SM, et al. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The transfusion safety study group. Transfusion. 1991 Jan;31(1):4–11.
- Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019 Apr 25;133(17):1854–1864.
- Dodd R. Emerging infections and transfusion safety. In: Murphy M, Roberts D, and Yazer M, et al. editors. Practical Transfusion Medicine. 6th ed. New Jersey, USA: Wiley Online Library; 2022. p. 229–237.
- Leiby DA, O’Brien SF, Wendel S, et al. International survey on the impact of parasitic infections: frequency of transmission and current mitigation strategies. Vox Sang. 2019 Jan;114(1):17–27.
- Sabino EC, Loureiro P, Lopes ME, et al. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis. 2016 Mar 1;213(5):694–702. DOI:10.1093/infdis/jiv326
- Bloch EM, Ness PM, Tobian AAR, et al. Revisiting blood safety practices given emerging data about zika virus. N Engl J Med. 2018 May 10;378(19):1837–1841. DOI:10.1056/NEJMsb1704752
- Smethurst PA, McAndrew M, Proffitt S, et al. Evaluating apheresis platelets at reduced dose as a contingency measure for extreme shortages. Transfusion. 2022 Jan;62(1):173–182.
- Cross AR American red cross faces severe blood shortage as coronavirus outbreak threatens availability of nation’s supply 2020 [updated Mar 17 2020; February 3, 2023]. Available from: https://www.redcross.org/about-us/news-and-events/press-release/2020/american-red-cross-faces-severe-blood-shortage-as-coronavirus-outbreak-threatens-availability-of-nations-supply.html
- Wang Y, Han W, Pan L, et al. Impact of COVID-19 on blood centres in Zhejiang province China. Vox Sang. 2020 Aug;115(6):502–506.
- Yahia AIO. Management of blood supply and demand during the COVID-19 pandemic in king abdullah hospital, bisha, Saudi Arabia. Transfus Apher Sci. 2020 Oct;59(5):102836.
- Pagano MB, Hess JR, Tsang HC, et al. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State. Transfusion. 2020 May;60(5):908–911.
- Al-Riyami AZ, Abdella YE, Badawi MA, et al. The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region. Transfus Clin Biol. 2021 Feb;28(1):16–24. DOI:10.1016/j.tracli.2020.11.002
- Al-Riyami AZ, Burnouf T, Wood EM, et al. International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic. Vox Sang. 2022 Jun;117(6):822–830.
- Chandler T, Neumann-Böhme S, Sabat I, et al. Blood donation in times of crisis: early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries. Vox Sang. 2021 Nov;116(10):1031–1041.
- Kumar S, Azim D, Nasim S, et al. Dwindling blood reserves: an ominous downside of COVID-19 pandemic. Transfus Apher Sci. 2020 Oct;59(5):102818.
- Brest M Surgeon general urges young people to donate blood to help hospitals during coronavirus pandemic: washington Examiner; 2020 [updated Mar 19 2020; February 3, 2023]. Available from: https://www.washingtonexaminer.com/news/surgeon-general-urges-young-people-to-donate-blood-to-help-hospitals-during-coronavirus-pandemic
- Gammon R, Katz LM, Strauss D, et al. Beyond COVID-19 and lessons learned in the United States. Transfus Med. 2022 Aug 2;33(1):6–15.
- Gammon RR, Prichard AB, Gannett MS, et al. The effect of COVID-19 on blood donation habits. Transfusion. 2021 Apr;61(4):1134–1140.
- Veseli B, Sandner S, Studte S, et al. The impact of COVID-19 on blood donations. PLoS ONE. 2022;17(3):e0265171. DOI:10.1371/journal.pone.0265171
- News T Risk of Transfusion Transmission of SARS-CoV-2 is Only Theoretical: John Wiley & Sons, Inc. All Rights; 2020 [updated Mar 4 2020; February 8, 2023]. Available from: www.transfusionnews.com/2020/03/04/risk-of-transfusion-transmission-of-sars-cov-2-is-only-theoretical/
- Cappy P, Candotti D, Sauvage V, et al. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation. Blood. 2020 Oct 15;136(16):1888–1891. DOI:10.1182/blood.2020008230
- Mohammadi S, Tabatabaei Yazdi SM, Eshghi P, et al. Coronavirus disease 2019 (COVID-19) and decrease in blood donation: experience of iranian blood transfusion organization (IBTO). Vox Sang. 2020 Oct;115(7):595–596.
- Sachdev S, Kishore K, Singh L, et al. Exploration of COVID-19 related fears deterring from blood donation in India. ISBT Sci Ser. 2021 May;16(2):147–157.
- Sayedahmed AMS, Ali KAM, Ali SBS, et al. Coronavirus disease (COVID-19) and decrease in blood donation: a cross-sectional study from Sudan. ISBT Sci Series. 2020;15(4):381–385. DOI:10.1111/voxs.12575
- Barnes LS, Al-Riyami AZ, Ipe TS, et al. COVID-19 and the impact on blood availability and transfusion practices in low- and middle-income countries. Transfusion. 2022 Feb;62(2):336–345. DOI:10.1111/trf.16798
- Ranney ML, Griffeth V, Jha AK. Critical supply shortages - the need for ventilators and personal protective equipment during the covid-19 pandemic. N Engl J Med. 2020 Apr 30;382(18):e41.
- Italy’s Lombardy asks retired health workers to join coronavirus fight [Internet]. 2020. Available from: www.weforum.org/agenda/2020/03/italys-lombardy-etired-health-workers-coronavirus-covid19-pandemic
- Balmer C, Pollina E Italy’s Lombardy asks retired health workers to join coronavirus fight 2020 [Jan 4, 2023]. Available from: www.weforum.org/agenda/2020/03/italys-lombardy-etired-health-workers-coronavirus-covid19-pandemic/
- Burki T. Global shortage of personal protective equipment. Lancet Infect Dis. 2020 Jul;20(7):785–786.
- Carroll WD, Strenger V, Eber E, et al. European and United Kingdom COVID-19 pandemic experience: the same but different. Paediatr Respir Rev. 2020 Sep;35:50–56.
- Shortage of personal protective equipment endangering health workers worldwide [Internet]. World Health Organization; 2020; [dec 1 2022]. Available from: www.who.int/news/item/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide
- FDABlood specimen collection tube shortage: frequently asked questions: food and drug administration1dec 7 2022 Available fromwww.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/blood-specimen-collection-tube-shortage-frequently-asked-questions
- Carson JL, Guyatt G, Heddle NM, et al. Clinical Practice Guidelines from the AABB: red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016 Nov 15;316(19):2025–2035. DOI:10.1001/jama.2016.9185
- Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD002042. DOI:10.1002/14651858.CD002042.pub4
- Klein HG, Hrouda JC, Epstein JS. Crisis in the Sustainability of the U.S. Blood System. N Engl J Med. 2018 Jan 18;378(3):305–306.
- Collaborative C. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. 2020 Oct;107(11):1440–1449.
- ACo S. COVID-19 guidelines for triage of cancer surgery patients: american college of surgeons; 2020 [updated Mar 24 2020; 11 dec 2022]. Available from: www.facs.org/covid-19/clinical-guidance/elective-case/cancer-surgery
- Gehrie EA, Frank SM, Goobie SM. Balancing Supply and Demand for Blood during the COVID-19 Pandemic. Anesthesiology. 2020 Jul;133(1):16–18. DOI:10.1097/ALN.0000000000003341
- Greenhalgh M, Dupley L, Unsworth R, et al. Where did all the trauma go? A rapid review of the demands on orthopaedic services at a UK Major Trauma Centre during the COVID-19 pandemic. Int J Clin Pract. 2021 Mar;75(3):e13690.
- Wieck MM, Silva T, Kohler JE. Changing patterns of pediatric trauma during the COVID-19 Pandemic. Pediatr Ann. 2022 Jul;51(7):e286–290.
- Raitio A, Ahonen M, Jääskelä M, et al. Reduced Number of pediatric orthopedic trauma requiring operative treatment during COVID-19 restrictions: a nationwide cohort study. Scand J Surg. 2021 Jun;110(2):254–257.
- Fan BE, Ong KH, Chan SSW, et al. Blood and blood product use during COVID-19 infection. Am J Hematol. 2020 Jul;95(7):E158–160.
- Kracalik I, Mowla S, Katz L, et al. Impact of the early coronavirus disease 2019 pandemic on blood utilization in the United States: a time-series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module. Transfusion. 2021 Sep;2(Suppl 2):S36–43.
- Marano G, Vaglio S, Pupella S, et al. Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus. 2016 Mar;14(2):152–157.
- Shen C, Wang Z, Zhao F, et al. Treatment of 5 Critically Ill Patients with COVID-19 with convalescent plasma. JAMA. 2020 Apr 28;323(16):1582–1589. DOI:10.1001/jama.2020.4783
- Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490–9496. DOI:10.1073/pnas.2004168117
- Xinhua. China puts 245 COVID-19 patients on convalescent plasma therapy 2020 [nov 7 2022]. Available from: www.xinhuanet.com/english/2020-02/28/c_138828177.htm
- Bloch EM, Shoham S, Casadevall A, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 Jun 1;130(6):2757–2765. DOI:10.1172/JCI138745
- Bloch EM, Goel R, Wendel S, et al. Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries. Vox Sang. 2021 Jan;116(1):18–35.
- Franchini M, Del Fante C, Klersy C, et al. Challenges in the production of convalescent hyperimmune plasma in the age of COVID-19. Semin Thromb Hemost. 2020 Oct;46(7):804–806.
- Tiberghien P, de Lamballerie X, Morel P, et al. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how? Vox Sang. 2020 Aug;115(6):488–494.
- Administration Fa D Recommendations for Investigational COVID-19 Convalescent Plasma 2020 [updated Jan 10, 2022]. Available from: www.fda.gov/vaccines-blood-biologics/investigational-new-drug-applications-inds-cber-regulated-products/recommendations-investigational-covid-19-convalescent-plasma
- Gharbharan A, Jordans CCE, GeurtsvanKessel C, et al. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection. Nat Commun. 2021 May 27;12(1):3189. DOI:10.1038/s41467-021-23469-2
- Nguyen FT, van den Akker T, Lally K, et al. Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2. Transfusion. 2021 Jan;61(1):78–93.
- Simonovich VA, Burgos Pratx LD, Scibona P, et al. A randomized trial of convalescent plasma in covid-19 severe pneumonia. N Engl J Med. 2021 Feb 18;384(7):619–629. DOI:10.1056/NEJMoa2031304
- Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a Randomized Clinical Trial. JAMA. 2020 Aug 4;324(5):460–470. DOI:10.1001/jama.2020.10044
- Libster R, Pérez Marc G, Wappner D, et al. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med. 2021 Feb 18;384(7):610–618. DOI:10.1056/NEJMoa2033700
- Senefeld JW, Johnson PW, Kunze KL, et al. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: a national registry study. PLOS Med. 2021 Dec;18(12):e1003872.
- Abani O, Abbas A, Abbas F, et al. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet. 2021 May 29; 397(10289):2049–2059. DOI:10.1016/S0140-6736(21)00897-7
- Bar KJ, Shaw PA, Choi GH, et al. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. J Clin Invest. 2021 Dec 15;131(24). DOI:10.1172/JCI155114
- Estcourt LJ, Turgeon AF, McQuilten ZK, et al. Effect Of convalescent plasma on organ support-free days in critically Ill patients with COVID-19: A randomized clinical trial. JAMA. 2021 Nov 2;326(17):1690–1702. DOI:10.1001/jama.2021.18178
- Sullivan DJ, Gebo KA, Shoham S, et al. Early Outpatient Treatment for Covid-19 with Convalescent Plasma. N Engl J Med. 2022 May 5;386(18):1700–1711. DOI:10.1056/NEJMoa2119657
- Cohn CS, Estcourt L, Grossman BJ, et al. COVID-19 convalescent plasma: interim recommendations from the AABB. Transfusion. 2021 Apr;61(4):1313–1323.
- Piechotta V, Chai KL, Valk SJ, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. DOI:10.1002/14651858.CD013600.pub2
- Shoham S, Bloch EM, Casadevall A, et al. Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial. Clin Infect Dis. 2022 May 17;76(3): e477–e486.
- Agarwal A, Mukherjee A, Kumar G, et al. Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ. 2020 Oct 22;371:m3939. DOI:10.1136/bmj.m3939
- Joyner MJ, Bruno KA, Klassen SA, et al. Safety Update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin Proc. 2020 Sep;95(9):1888–1897.
- Salman OH, Mohamed HSA. Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study. Egypt J Anaesth. 2020;1(1):264–272.
- Estcourt LJ, Cohn CS, Pagano MB, et al. Clinical practice guidelines from the association for the advancement of blood and biotherapies (AABB): COVID-19 convalescent plasma. Ann Intern Med. 2022 Sep;175(9):1310–1321.
- Millat-Martinez P, Gharbharan A, Alemany A, et al. Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients. Nat Commun. 2022 May 11;13(1):2583. DOI:10.1038/s41467-022-29911-3
- Kunze KL, Johnson PW, van Helmond N, et al. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 Aug 11;12(1):4864. DOI:10.1038/s41467-021-25113-5
- Bloch EM, Focosi D, Shoham S, et al. Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19. Clinl Infect Dis. 2023. DOI:10.1093/cid/ciad066.
- Iannizzi C, Chai KL, Piechotta V, et al. Convalescent plasma for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2023 Feb 1;2 CD0136002. DOI:10.1002/14651858.CD013600.pub5
- Burnouf T, Gathof B, Bloch EM, et al. Production and quality assurance of human polyclonal hyperimmune immunoglobulins against SARS-CoV-2. Transfus Med Rev. 2022 Jul;36(3):125–132.
- Burnouf T. Modern plasma fractionation. Transfus Med Rev. 2007 Apr;21(2):101–117.
- Polizzotto MN, Nordwall J, Babiker AG, et al. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Lancet. 2022 Feb 5; 399(10324):530–540. DOI:10.1016/S0140-6736(22)00101-5
- Kimber C, Valk SJ, Chai KL, et al. Hyperimmune immunoglobulin for people with COVID-19. Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD015167. DOI:10.1002/14651858.CD015167.pub2
- Roberts N, James S, Delaney M, et al. The global need and availability of blood products: a modelling study. Lancet Haematol. 2019 Dec;6(12):e606–615.
- Oreh AC, Irechukwu C, Biyama F, et al. COVID-19 impact on Nigeria’s national blood service commission - Lessons for Low- and Middle-Income Countries (LMICs). Niger Postgrad Med J. 2022;29(1):6–12. DOI:10.4103/npmj.npmj_720_21
- Maghsudlu M, Eshghi P, Amini Kafi-Abad S, et al. Blood supply sufficiency and safety management in Iran during the COVID-19 outbreak. Vox Sang. 2021 Feb;116(2):175–180.
- Organization WH Global status report on blood safety and availability 2021. 2022.
- Eleftheriou A, Cannon L, Angastinotis M. Thalassemia Reports 2020. 2020;10:9138:p. 7–11.
- Shet A, Ataga K, Wun T, et al. COVID-19 and sickle cell disease: frequently asked questions: American society for hematology. May 28 2021 [ nov 30 2022]. Available from: www.hematology.org/covid-19/covid-19-and-sickle-cell-disease
- Panel NH Supporting the transfusion needs of patients with inherited red cell disorders during the COVID-19 pandemic in England: a phased approach. British Society for Haematology; Apr 6, 2020 [nov 30 2022]. Available from: b-s-h.org.uk/media/18230/supporting-the-transfusion-needs-of-patients-with-inherited-red-cell-disorders-during-the-covid-19-pandemic-in-england-v15420.pdf
- Al-Aiyami AZ, Daar S. Blood supply challenges and transfusion care of patients with hemoglobinopathies during COVID-19 pandemic. Annals Blood. 2020;5(31):31.
- Bloch EM, Goel R, Montemayor C, et al. Promoting access to COVID-19 convalescent plasma in low- and middle-income countries. Transfus Apher Sci. 2021 Feb;60(1):102957.
- Bloch EM, Simon MS, Shaz BH. Emerging infections and blood safety in the 21st century. Ann Intern Med. 2016 Mar 15;165(1):57.